Market Overview

AMN Healthcare Services Pulled From Avondale's Conviction Buy List, Reserved For More Patient Investors

Share:
AMN Healthcare Services Pulled From Avondale's Conviction Buy List, Reserved For More Patient Investors
Related AHS
Mid-Day Market Update: Mattress Firm Jumps Following Buyout; Digital Ally Shares Slide
Despite June Jobs Numbers, BMO Sees Staffing Stocks Reporting Sluggish Q2

Avondale Partners' Randle Reece removed AMN Healthcare Services, Inc. (NYSE: AHS) from the firm's conviction list while raising the company's price objective from $42.00 to $43.00.

The list was directed toward short-term investments driven by "specific catalysts," and AMN Healthcare Services does not fit that description according to Reece. "We find the stock to be suitable for more patient investors," said the analyst.

Related Link: Cramer's "Lightning Round" Picks And Passes: First Solar, Lending Club, Dominion Resources And More

Reece did acknowledge that "AHS is the leading company in a segment of the US staffing market that is growing much faster than any other." The EV/EBITDA premium is "unusually wide," however, and increasing labor costs are also a concern, as is an estimated "tightening labor supply" in the medical services industry looms.

AMN Healthcare closed Monday trading down 0.40 percent at $37.26.

Latest Ratings for AHS

DateFirmActionFromTo
Aug 2016UBSMaintainsBuy
May 2016Lake StreetInitiates Coverage onBuy
May 2016Avondale PartnersMaintainsMarket Outperform

View More Analyst Ratings for AHS
View the Latest Analyst Ratings

Posted-In: Analyst Color Long Ideas Health Care Price Target Analyst Ratings Trading Ideas General Real Estate

 

Related Articles (AHS)

View Comments and Join the Discussion!

Partner Center